Company / CapEx per Share
Kymera Therapeutics, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.01 / $0.72
FY2021-FY2025
Trend
-90.3%
vs FY2024
Sector context
#98 of 192
Health Care
What the data says
At $0.02, Kymera Therapeutics, Inc.'s capex per share ranks #98 of 192 in the Health Care sector. Declined from $0.72 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -39.5%.
Declined from $0.72 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -26.0%
- 5-Year CAGR
- -39.5%
- 10-Year CAGR
- -
Sector benchmark
#98 of 192 in Health CareTop 51% of 192This company $0.02 Sector average $2.46
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 90.3% year-over-year.
- Ranks #98 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2023.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -90.3% |
| FY2024 | $0.23 | -67.9% |
| FY2023 | $0.72 | +1205.7% |
| FY2022 | $0.06 | +360.1% |
| FY2021 | $0.01 | -95.7% |
| FY2020 | $0.28 | -12.0% |
| FY2019 | $0.31 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026